Suicide Attempt and Risk of Substance Use Disorders Among Female Youths.


Journal

JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550

Informations de publication

Date de publication:
01 07 2022
Historique:
pubmed: 12 5 2022
medline: 9 7 2022
entrez: 11 5 2022
Statut: ppublish

Résumé

Suicide attempts are prevalent among female youths, yet little is known about the subsequent development of substance use disorders. To assess the association between suicide attempts among females before 20 years of age and future risk of substance use disorders. In this longitudinal cohort study, females aged 8 to 19 years (hereafter referred to as youths) who attempted suicide were matched with female youths with no attempt between April 1, 1989, and March 31, 2019, in Quebec, Canada. The cohort was followed up for 31 years, for a total of 2 409 396 person-years, to identify subsequent substance use disorders. Confirmed suicide attempts among females 8 to 19 years of age. The main outcome measure was hospitalization for a substance use disorder later in life. Hazard ratios (HRs) and 95% CIs for the association of suicide attempt with substance use disorders were estimated using Cox proportional hazards regression models adjusted for baseline age, mental illness, resource-limited socioeconomic status, and year at start of follow-up. Among 122 234 female youths (mean [SD] age, 15.6 [1.9] years), 5840 (4.8%) attempted suicide and 4341 (3.6%) developed a substance use disorder. Compared with the 116 394 matched female youths who did not attempt suicide (95.2%), those who attempted suicide had a greater risk of hospitalization for any substance use disorder during the follow-up period (HR, 6.03; 95% CI, 5.39-6.77), especially sedative or hypnotic use disorders (HR, 32.24; 95% CI, 23.29-44.64). Suicide attempt was associated with the development of sedative or hypnotic use disorders up to 5 years (HR, 66.69; 95% CI, 34.72-128.09), although risks remained elevated up to 3 decades later for all substances. Compared with those without suicide attempt, female youths with 3 or more suicide attempts had 21.20 (95% CI, 13.53-32.90) times the risk of substance use disorders, whereas female youths with 1 attempt had 5.70 (95% CI, 5.08-6.41) times the risk of these disorders. In this cohort study, female youths who attempted suicide had increased risk of subsequent substance use disorders compared with female youths who did not attempt suicide. These findings suggest that closer management and prevention of substance use among female youths who attempt suicide may be beneficial.

Identifiants

pubmed: 35544235
pii: 2792405
doi: 10.1001/jamapsychiatry.2022.1025
pmc: PMC9096685
doi:

Substances chimiques

Hypnotics and Sedatives 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

710-717

Subventions

Organisme : CIHR
ID : PJT-156062
Pays : Canada

Références

J Am Acad Child Adolesc Psychiatry. 2017 Nov;56(11):958-965.e4
pubmed: 29096778
Drug Alcohol Depend. 2004 Dec 7;76 Suppl:S79-91
pubmed: 15555819
PLoS One. 2021 Aug 6;16(8):e0255799
pubmed: 34358273
Health Educ Res. 2001 Aug;16(4):457-69
pubmed: 11525392
Health Promot Chronic Dis Prev Can. 2016 Nov;36(11):243-251
pubmed: 27882859
Yale J Biol Med. 2015 Sep 03;88(3):247-56
pubmed: 26339207
Depress Anxiety. 2015 Apr;32(4):270-6
pubmed: 25421360
Aust N Z J Psychiatry. 2020 Jan;54(1):7-9
pubmed: 31852236
J Affect Disord. 2018 Oct 1;238:563-569
pubmed: 29940520
Subst Abuse. 2008 Oct 31;2:13-28
pubmed: 20651946
Psychol Med. 2020 May;50(7):1214-1223
pubmed: 31144614
Clin Pediatr Emerg Med. 2013 Mar 1;14(1):28-34
pubmed: 25904825
Chronic Dis Inj Can. 2014 Feb;34(1):12-22
pubmed: 24618377
J Clin Psychiatry. 2017 Jun;78(6):e622-e630
pubmed: 28355042
BMJ. 2014 Oct 21;349:g5954
pubmed: 25335825
J Adolesc Health. 2020 Sep;67(3):354-361
pubmed: 32693983
Heart. 2004 Aug;90(8):956-60
pubmed: 15253985
Addict Behav. 2017 Feb;65:296-301
pubmed: 27569697
Can J Psychiatry. 2018 Mar;63(3):170-177
pubmed: 29202664
Arch Pediatr Adolesc Med. 2005 Sep;159(9):860-6
pubmed: 16143746
MMWR Suppl. 2020 Aug 21;69(1):47-55
pubmed: 32817610
JAMA Psychiatry. 2014 Feb;71(2):119-27
pubmed: 24306041
Psychol Med. 2005 Jul;35(7):983-93
pubmed: 16045065
Acta Psychiatr Scand. 2019 May;139(5):454-463
pubmed: 30865285

Auteurs

Nathalie Auger (N)

University of Montreal Hospital Research Centre, Montreal, Quebec, Canada.
Institut national de santé publique du Québec, Montreal, Quebec, Canada.
Department of Social and Preventive Medicine, School of Public Health, University of Montreal, Montreal, Quebec, Canada.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.

Nicholas Chadi (N)

Division of Adolescent Medicine, Department of Pediatrics, Sainte-Justine University Hospital Centre, University of Montreal, Montreal, Quebec, Canada.

Aimina Ayoub (A)

University of Montreal Hospital Research Centre, Montreal, Quebec, Canada.
Institut national de santé publique du Québec, Montreal, Quebec, Canada.

Émilie Brousseau (É)

University of Montreal Hospital Research Centre, Montreal, Quebec, Canada.
Institut national de santé publique du Québec, Montreal, Quebec, Canada.

Nancy Low (N)

Department of Psychiatry, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH